Mr. Ian Atacan reports

PHARMACIELO ANNOUNCES INTENTION TO ISSUE INTEREST SHARES

Pharmacielo Ltd. intends to issue, subject to the approval of the TSX Venture Exchange, 11,145,999 common shares of Pharmacielo, at an effective price of eight cents per interest share, in satisfaction of an aggregate of $891,681.85 in accrued semi-annual interest payments due to holders of the company's 11-per-cent secured debentures.

The effective price of the interest shares was determined by dividing the cash interest otherwise payable by the number of shares issuable under each debenture, in accordance with the terms of the debentures and TSX Venture Exchange Policy 4.3, Section 3.3.

The interest shares are subject to the balance, if any, of the applicable statutory hold period under Canadian securities laws.

About Pharmacielo Ltd.

Pharmacielo is a global company, headquartered in Canada, with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis extracts for the natural pharmaceuticals and consumer products market. Pharmacielo's principal (and wholly owned) subsidiary is Pharmacielo Colombia Holdings S.A.S., headquartered at its cultivation and processing centre located in Rionegro, Colombia.

We seek Safe Harbor.